Syndax Pharmaceuticals (SNDX) Accumulated Depreciation & Amortization: 2015-2023
- Syndax Pharmaceuticals' Accumulated Depreciation & Amortization rose 3.01% to $411,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.7 million, marking a year-over-year increase of 6.51%. This contributed to the annual value of $411,000 for FY2023, which is 3.01% up from last year.
- Syndax Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $411,000 in Q4 2023, which was up 3.01% from $399,000 recorded in Q4 2022.
- In the past 5 years, Syndax Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $443,000 during Q4 2021, and its lowest value of $310,000 during Q4 2019.
- Over the past 3 years, Syndax Pharmaceuticals' median Accumulated Depreciation & Amortization value was $411,000 (recorded in 2023), while the average stood at $417,667.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 31.91% in 2019, then dropped by 9.93% in 2022.
- Quarterly analysis of 5 years shows Syndax Pharmaceuticals' Accumulated Depreciation & Amortization stood at $310,000 in 2019, then grew by 28.71% to $399,000 in 2020, then climbed by 11.03% to $443,000 in 2021, then dropped by 9.93% to $399,000 in 2022, then climbed by 3.01% to $411,000 in 2023.
- Its Accumulated Depreciation & Amortization was $411,000 in Q4 2023, compared to $399,000 in Q4 2022 and $443,000 in Q4 2021.
